Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending December 18, 2015. The document serves as a notification of transactions involving directors, persons discharging managerial responsibilities (PDMR), or connected persons, in compliance with DTR 3.1.4R(1)(a) and (c).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing discloses a specific transaction involving Mr. R Connor, a PDMR. On December 18, 2015, 18,875 Ordinary Shares were transferred from a nominee holding to a Connected Person for nil consideration. No other material changes to the company's operations or financial position are reported in this document.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transfer described above.
Key Facts for Investor Verification
- Transaction Date: December 18, 2015.
- Individual Involved: Mr. R Connor (PDMR).
- Transaction Type: Transfer of 18,875 Ordinary Shares to a Connected Person.
- Consideration: Nil.
- Reporting Authority: Victoria Whyte, Company Secretary.